Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Basic Clin Neurosci ; 11(4): 403-412, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-33613878

RESUMEN

INTRODUCTION: The use of opioids such as morphine has anti-pain effects along with some side effects on body organs. Opioids such as morphine can be transferred from mother to child through the placenta and or breastfeeding. This study aimed to assess the effect of morphine on mineral content and histological changes of incisor teeth of rats born to morphine-addicted mothers. METHODS: In this experimental animal study, 24 pregnant rats were randomly divided into 6 groups of control, morphine, zinc, vitamin D, morphine plus zinc, and morphine plus vitamin D. After completion of the breastfeeding period, two babies were randomly selected among the newborns of each mother rat. Mineral content was analyzed using the Rontec device. The obtained data were analyzed by Newman-Keuls multiple comparisons test in Prism 5. RESULTS: Results showed a significant reduction in fluorine content in the experimental groups compared with the control group (P<0.05). The magnesium content in the experimental groups was significantly higher than that in the control group (P<0.05). Microscopic assessment of the slides showed a significantly less enamel maturation in the experimental groups compared with the control group (P<0.05). CONCLUSION: Morphine use by mothers decreased the fluorine content of tooth structure and retarded the maturity of the enamel of infants.

2.
Physiol Behav ; 188: 25-31, 2018 05 01.
Artículo en Inglés | MEDLINE | ID: mdl-29421337

RESUMEN

The role of dopaminergic system in modulation of formalin-induced orofacial nociception has been established. The present study aims to investigate the role of dopaminergic receptors in the nucleus accumbens (NAc) in modulation of nociceptive responses induced by formalin injection in the orofacial region. One hundred and six male Wistar rats were unilaterally implanted with two cannulae into the lateral hypothalamus (LH) and NAc. Intra-LH microinjection of carbachol, a cholinergic receptor agonist, was done 5min after intra-accumbal administration of different doses of SCH23390 (D1-like receptor antagonist) or sulpiride (D2-like receptor antagonist). After 5min, 50µl of 1% formalin was subcutaneously injected into the upper lip for inducing the orofacial pain. Carbachol alone dose-dependently reduced both phases of the formalin-induced orofacial pain. Intra-accumbal administration of SCH23390 (0.25, 1 and 4µg/0.5µl saline) or sulpiride (0.25, 1 and 4µg/0.5µl DMSO) before LH stimulation by carbachol (250nM/0.5µl saline) antagonized the antinociceptive responses during both phases of orofacial formalin test. The effects of D1- and D2-like receptor antagonism on the LH stimulation-induced antinociception were almost similar during the early phase. However, compared to D1-like receptor antagonism, D2-like receptor antagonism was a little more effective but not significant, at blocking the LH stimulation-induced antinociception during the late phase of formalin test. The findings revealed that there is a direct or indirect neural pathway from the LH to the NAc which is at least partially contributed to the modulation of formalin-induced orofacial nociception through recruitment of both dopaminergic receptors in this region.


Asunto(s)
Dolor Facial/patología , Área Hipotalámica Lateral/fisiología , Núcleo Accumbens/metabolismo , Receptores de Dopamina D1/metabolismo , Analgésicos/uso terapéutico , Analgésicos no Narcóticos/farmacología , Análisis de Varianza , Animales , Carbacol/farmacología , Modelos Animales de Enfermedad , Dopaminérgicos/farmacología , Relación Dosis-Respuesta a Droga , Dolor Facial/inducido químicamente , Dolor Facial/tratamiento farmacológico , Fijadores/toxicidad , Formaldehído/toxicidad , Área Hipotalámica Lateral/efectos de los fármacos , Microinyecciones , Núcleo Accumbens/efectos de los fármacos , Dimensión del Dolor , Ratas , Ratas Wistar , Receptores de Dopamina D2 , Factores de Tiempo
3.
Peptides ; 99: 217-222, 2018 01.
Artículo en Inglés | MEDLINE | ID: mdl-29042271

RESUMEN

The role of hippocampus and lateral hypothalamus (LH) in modulation of formalin-induced nociception has been established. The present study aims to examine the role of orexin receptors in the Cornu Ammonis 1 (CA1) region of hippocampus in modulation of the LH-induced antinociception in the orofacial formalin test. Male Wistar rats were unilaterally implanted with two cannulae into the LH and CA1. Intra-LH microinjection of carbachol was done 5min after intra-CA1 administration of SB-334867 (OX1R antagonist) or TCS OX2 29 (OX2R antagonist). After 5min, 50µl of 1% formalin was subcutaneously injected into the upper lip for inducing the nociceptive behaviors. Solely intra-LH administration of carbachol reduced early and late phases of formalin-induced orofacial nociception in a dose-dependent manner. The antinociception evoked by intra-LH injection of carbachol (0.5µl of 250nM carbachol) was antagonized by intra-CA1 administration of 0.5µl of 3, 10 and 30nM solutions of SB-334867 or TCS OX2 29 during the early and late phases of orofacial formalin test. This effect was more remarkable during the late phase in comparison to the early phase. In addition, anti-analgesic effect of SB-334867 was more than TCS OX2 29 during the early and late phases. The results suggest the interpretation that a neural pathway from the LH to the CA1 probably contributes to the modulation of formalin-induced orofacial nociception through recruitment of both CA1 orexin receptors. Clinical studies are recommended to study the probable effectiveness of orexinergic system in modulation of the orofacial nociceptive responses.


Asunto(s)
Analgésicos/farmacología , Región CA1 Hipocampal/metabolismo , Dolor Facial , Formaldehído/toxicidad , Isoquinolinas/farmacología , Antagonistas de los Receptores de Orexina/farmacología , Piridinas/farmacología , Animales , Benzoxazoles/farmacología , Dolor Facial/inducido químicamente , Dolor Facial/tratamiento farmacológico , Dolor Facial/metabolismo , Masculino , Naftiridinas , Receptores de Orexina/agonistas , Receptores de Orexina/metabolismo , Ratas , Ratas Wistar , Urea/análogos & derivados , Urea/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA